Methodological research progress on the trajectory of chronic disease multimorbidity

WEI Conghan; LIANG Lizhong; ZENG Zhirong

doi:10.16462/j.cnki.zhjbkz.2024.08.016

Volume 28 Issue 8

Aug. 2024

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2024 > 28(8): 969-975

WEI Conghan, LIANG Lizhong, ZENG Zhirong. Methodological research progress on the trajectory of chronic disease multimorbidity[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(8): 969-975. doi: 10.16462/j.cnki.zhjbkz.2024.08.016

Citation:

WEI Conghan, LIANG Lizhong, ZENG Zhirong. Methodological research progress on the trajectory of chronic disease multimorbidity[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(8): 969-975. doi: 10.16462/j.cnki.zhjbkz.2024.08.016

Citation:

PDF( 7725 KB)

Methodological research progress on the trajectory of chronic disease multimorbidity

doi: 10.16462/j.cnki.zhjbkz.2024.08.016

1.
Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan 523808, China
2.
Institute of Healthcare Security, Guangdong Medical University, Zhanjiang 524023, China
3.
Institute of Public Health and Wellness, Guangdong Medical University, Zhanjiang 524023, China

More Information

Corresponding author: ZENG Zhirong, E-mail: zengzrgdy@gdmu.edu.cn
Received Date: 2024-01-01
Rev Recd Date: 2024-05-15

Available Online: 2024-09-29

Publish Date: 2024-08-10

Abstract

Abstract

As the aging of the population intensifies and the spectrum of diseases in the population changes, the complexity of multimorbidities of chronic diseases is increasing. Clarifying the progression patterns of multimorbidities over time will provide points for further research. This study analyzes the concepts related to chronic disease multimorbidity trajectories, systematically reviews the literature visualization, and summarizes the methodological advances and research findings from three research perspectives: variable-centered, individual-centered, and disease diagnosis-centered. The development of chronic disease multimorbidity trajectory research will provide evidence to early detect disease risks, implement interventions, delay and control disease progression, and have important reference significance in identifying the mechanisms of multimorbidity occurrence and optimizing health resource allocation.
- Chronic disease,
- Comorbidity,
- Multimorbidity,
- Multimorbidity trajectories,
- Methodology

FullText(HTML)

References(46)

References

[1]	Hajat C, Stein E. The global burden of multiple chronic conditions: a narrative review[J]. Prev Med Rep, 2018, 12: 284-293. DOI: 10.1016/j.pmedr.2018.10.008.
[2]	The Academy of Medical Sciences. Multimorbidity: a priority for global health research[M]. London, 2018: 36-40.
[3]	Cezard G, McHale CT, Sullivan F, et al. Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence[J]. BMJ Open, 2021, 11(11): e048485. DOI: 10.1136/bmjopen-2020-048485.
[4]	Zhu ZC, Heng BH, Teow KL. Lifetime trajectory simulation of chronic disease progression and comorbidity development[J]. J Biomed Inform, 2018, 88: 29-36. DOI: 10.1016/j.jbi.2018.11.002.
[5]	Jensen AB, Moseley PL, Oprea TI, et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients[J]. Nat Commun, 2014, 5: 4022. DOI: 10.1038/ncomms5022.
[6]	闫泽玉, 陈大方. 慢性病共病模式研究进展[J]. 中华疾病控制杂志, 2023, 27(4): 471-475. DOI: 10.16462/j.cnki.zhjbkz.2023.04.017. Yan ZY, Chen DF. Research progress on the patterns of multimorbidity[J]. Chin J Dis Control Prev, 2023, 27(4): 471-475. DOI: 10.16462/j.cnki.zhjbkz.2023.04.017.
[7]	Corbin JM, Strauss A. A nursing model for chronic illness management based upon the Trajectory Framework[J]. Sch Inq Nurs Pract, 1991, 5(3): 155-174.
[8]	Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives[J]. Int J Epidemiol, 2002, 31(2): 285-293. doi: 10.1093/ije/31.2.285
[9]	Kuh D, Ben-Shlomo Y, Lynch J, et al. Life course epidemiology[J]. J Epidemiol Community Health, 2003, 57(10): 778-783. DOI: 10.1136/jech.57.10.778.
[10]	巫锡炜, 刘慧. 中国老年人虚弱变化轨迹及其分化: 基于虚弱指数的考察[J]. 人口研究, 2019, 43(4): 70-84. Wu XW, Liu H. Frailty trajectory and its differentials among older adults in China: an investigation based on frailty index[J]. Population Research, 2019, 43(4): 70-84.
[11]	Chen LN, Liu R, Liu ZP, et al. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers[J]. Sci Rep, 2012, 2: 342. DOI: 10.1038/srep00342.
[12]	Liu R, Wang XD, Aihara K, et al. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers[J]. Med Res Rev, 2014, 34(3): 455-478. DOI: 10.1002/med.21293.
[13]	李灿东, 俞洁, 甘慧娟, 等. 中西医病证结合研究应重视的几个问题[C]. 中国中西医结合学会诊断专业委员会. 中国中西医结合学会第六届全国诊断学术会议论文集. 福建: 福建中医药大学中医证研究基地, 2012: 140-145. Li CD, Yu J, Gan HJ, et al. Some points for the research of combination of disease and TCM syndrome[C] Diagnostic Committee of the Chinese Society of Integrative Medicine. The 6th National Diagnostic Academic Conference of the Chinese Association of Integrative Medicine. Research Base of Traditional Chinese Medicine Syndrome, Fujian University of Chinese Medicine, 2012: 140-145.
[14]	王雅晶, 汪雅霜. 从"变量中心"到"个体中心": 潜变量混合模型基本原理及其应用[J]. 湖北社会科学, 2023(5): 137-145. DOI: 10.13660/j.cnki.42-1112/c.016110. Wang YJ, Wang YS. From"Variable Center" to "Individual Center": Basic Principles and Applications of Latent Variable Mixed Models[J]. Hubei Soc Sci, 2023(5): 137-145. DOI: 10.13660/j.cnki.42-1112/c.016110.
[15]	尹奎, 彭坚, 张君. 潜在剖面分析在组织行为领域中的应用[J]. 心理科学进展, 2020, 28(7): 1056-1070. DOI: 10.3724/SP.J.1042.2020.01056. Yin K, Peng J, Zhang J. The application of latent profile analysis in organizational behavior research[J]. Adv Psychol Sci, 2020, 28(7): 1056-1070. DOI: 10.3724/SP.J.1042.2020.01056.
[16]	Ashworth M, Durbaba S, Whitney D, et al. Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting[J]. BMJ Open, 2019, 9(12): e031649. DOI: 10.1136/bmjopen-2019-031649.
[17]	Stannard S, Holland E, Crozier SR, et al. Early-onset burdensome multimorbidity: an exploratory analysis of sentinel conditions, condition accrual sequence and duration of three long-term conditions using the 1970 British Cohort Study[J]. BMJ Open, 2022, 12(10): e059587. DOI: 10.1136/bmjopen-2021-059587.
[18]	陈启光. 纵向研究中重复测量资料的广义估计方程分析[J]. 中国卫生统计, 1995, 12(1): 22-25. Chen QG. The analysis of longitudinal data using generalized estimating equations[J]. Chinese Journal of Health Statistics, 1995, 12(1): 22-25.
[19]	Xu XL, Mishra GD, Dobson AJ, et al. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study[J]. PLoS Med, 2018, 15(3): e1002516. DOI: 10.1371/journal.pmed.1002516.
[20]	Huang ZT, Luo Y, Han L, et al. Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese[J]. J Affect Dis, 2022, 301: 1-7. DOI: 10.1016/j.jad.2022.01.030.
[21]	Detry MA, Ma Y. Analyzing repeated measurements using mixed models[J]. JAMA, 2016, 315(4): 407-408. DOI: 10.1001/jama.2015.19394.
[22]	Calderón-Larraaga A, Saadeh M, Hooshmand B, et al. Association of homocysteine, methionine, and MTHFR 677C>T polymorphism with rate of cardiovascular multimorbidity development in older adults in Sweden[J]. JAMA Netw Open, 2020, 3(5): e205316. DOI: 10.1001/jamanetworkopen.2020.5316.
[23]	Wubben N, Haaksma M, Ramakers IHGB, et al. A comparison of two approaches for modeling dementia progression in a changing patient context[J]. International journal of geriatric psychiatry, 2022, 37(5). DOI: 10.1002/GPS.5706.
[24]	冯国双. 重复测量数据的常用统计分析方法[J]. 中华预防医学杂志, 2020, 54(7): 804-812. DOI: 10.3760/cma.j.cn112150-20200514-00728. Feng GS. Statistical methods for repeated measurement data in scientific research[J]. Chin J Prev Med, 2020, 54(7): 804-812. DOI: 10.3760/cma.j.cn112150-20200514-00728.
[25]	Wister A, Cosco T, Mitchell B, et al. Health behaviors and multimorbidity resilience among older adults using the Canadian Longitudinal Study on Aging[J]. Int Psychogeriatr, 2020, 32(1): 119-133. DOI: 10.1017/S1041610219000486.
[26]	Wister A, Li L, Whitmore C, et al. Multimorbidity resilience and health behaviors among older adults: a longitudinal study using the Canadian Longitudinal Study on Aging[J]. Front Public Health, 2022, 10: 896312. DOI: 10.3389/fpubh.2022.896312.
[27]	Shang XW, Zhang XL, Huang Y, et al. Temporal trajectories of important diseases in the life course and premature mortality in the UK Biobank[J]. BMC Med, 2022, 20(1): 185. DOI: 10.1186/s12916-022-02384-3.
[28]	李卫芹, 杨雷, 王胜锋, 等. 生存数据的多状态竞争风险模型分析方法探索[J]. 中华预防医学杂志, 2021, 55(12): 1524-1529. DOI: 10.3760/cma.j.cn112150-20211103-01019. Li WQ, Yang L, Wang SF, et al. Application of multi-stage competing risk model to survival data[J]. Chin J Prev Med, 2021, 55(12): 1524-1529. DOI: 10.3760/cma.j.cn112150-20211103-01019.
[29]	Owen RK, Lyons J, Akbari A, et al. Effect on life expectancy of temporal sequence in a multimorbidity cluster of psychosis, diabetes, and congestive heart failure among 1·7 million individuals in Wales with 20-year follow-up: a retrospective cohort study using linked data[J]. Lancet Public Health, 2023, 8(7): e535-e545. DOI: 10.1016/S2468-2667(23)00098-1.
[30]	Vetrano DL, Roso-Llorach A, Fernández S, et al. Twelve-year clinical trajectories of multimorbidity in a population of older adults[J]. Nat Commun, 2020, 11(1): 3223. DOI: 10.1038/s41467-020-16780-x.
[31]	Curtis JR, Weinblatt M, Saag K, et al. Data-driven patient clustering and differential clinical outcomes in the brigham and women's rheumatoid arthritis sequential study registry[J]. Arthritis Care Res, 2021, 73(4): 471-480. DOI: 10.1002/acr.24471.
[32]	Ritschard G, Studer M. Sequence analysis: where are we, where are we going?[M]. Sequence Analysis and Related Approaches. Cham: Springer, 2018: 1-11. DOI: 10.1007/978-3-319-95420-2_1.
[33]	Haug N, Sorger J, Gisinger T, et al. Decompression of multimorbidity along the disease trajectories of diabetes mellitus patients[J]. Front Physiol, 2020, 11: 612604. DOI: 10.3389/fphys.2020.612604.
[34]	Cezard G, Sullivan F, Keenan K. Understanding multimorbidity trajectories in Scotland using sequence analysis[J]. Sci Rep, 2022, 12(1): 16485. DOI: 10.1038/s41598-022-20546-4.
[35]	Quiones AR, Newsom JT, Elman MR, et al. Racial and ethnic differences in multimorbidity changes over time[J]. Med Care, 2021, 59(5): 402-409. DOI: 10.1097/MLR.0000000000001527.
[36]	温忠麟, 谢晋艳, 王惠惠. 潜在类别模型的原理、步骤及程序[J]. 华东师范大学学报(教育科学版), 2023, 41(1): 1-15. DOI: 10.16382/j.cnki.1000-5560.2023.01.001. Wen ZL, Xie JY, Wang HH. Principles, procedures and programs of latent class models[J]. Journal of East China Normal University(Educational Sciences), 2023, 41(1): 1-15. DOI: 10.16382/j.cnki.1000-5560.2023.01.001.
[37]	Luo Y, Chen YM, Wang KP, et al. Associations between multimorbidity and frailty transitions among older Americans[J]. J Cachexia Sarcopenia Muscle, 2023, 14(2): 1075-1082. DOI: 10.1002/jcsm.13197.
[38]	Bendayan R, Zhu YJ, Federman AD, et al. Multimorbidity patterns and memory trajectories in older adults: evidence from the English longitudinal study of aging[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(5): 867-875. DOI: 10.1093/gerona/glab009.
[39]	Liu HY, Zhang XY, Chen BZ, et al. The differential impact of multimorbidity patterns and subsequent accumulation on longitudinal trajectories of physical function decline in a population-based cohort of older people[J]. J Gerontol A Biol Sci Med Sci, 2022, 77(8): 1629-1636. DOI: 10.1093/gerona/glab384.
[40]	Woodman RJ, Mangoni AA. A comprehensive review of machine learning algorithms and their application in geriatric medicine: present and future[J]. Aging Clin Exp Res, 2023, 35(11): 2363-2397. DOI: 10.1007/s40520-023-02552-2.
[41]	Haue AD, Armenteros JJA, Holm PC, et al. Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study[J]. Cardiovasc Diabetol, 2022, 21(1): 87. DOI: 10.1186/s12933-022-01527-3.
[42]	Jeong E, Park N, Kim Y, et al. Temporal trajectories of accompanying comorbidities in patients with type 2 diabetes: a Korean nationwide observational study[J]. Sci Rep, 2020, 10(1): 5535. DOI: 10.1038/s41598-020-62482-1.
[43]	Yong ZL, Luo L, Gu YH, et al. Bayesian comorbidity network and cost analysis for asthma[J]. IEEE J Biomed Health Inform, 2022, 26(9): 4714-4724. DOI: 10.1109/JBHI.2022.3182368.
[44]	Aguado A, Moratalla-Navarro F, López-Simarro F, et al. MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity[J]. Sci Rep, 2020, 10(1): 2416. DOI: 10.1038/s41598-020-59336-1.
[45]	Wang LY, Qiu H, Luo L, et al. Age- and sex-specific differences in multimorbidity patterns and temporal trends on assessing hospital discharge records in southwest China: network-based study[J]. J Med Internet Res, 2022, 24(2): e27146. DOI: 10.2196/27146.
[46]	Wang HY, Gao CF, Dantona C, et al. DRG-LLaMA: tuning LLaMA model to predict diagnosis-related group for hospitalized patients[J]. NPJ Digit Med, 2024, 7(1): 16. DOI: 10.1038/s41746-023-00989-3.